Menu

Pharma News

Shaking hands V13D29

Eisai acquires Chinese generics maker

Home/Pharma News | Posted 22/01/2016

Japanese pharmaceutical company Eisai announced on 28 December 2015 that it had acquired Chinese generics maker Liaoning TianYi Biological Pharmaceutical.

2015 V16A15

Top 10 most read GaBI Online articles in 2015

Home/Pharma News | Posted 15/01/2016

It has been a hectic year for biosimilars.  One of the most important milestones for biosimilars in 2015 was the finalization by the US Food and Drug Administration (FDA) of its regulatory guidelines for biosimilars. Other subjects of interest for biosimilars were the patent expiries of originator biologicals, clinical trials and extrapolation of indications. Biosimilars remain the hot topic for GaBI Online during 2015 and, in fact, all 10 of the most read articles concern biosimilars.

picture 80

Teva and Takeda partner for generics in Japan

Home/Pharma News | Posted 11/12/2015

Israeli generics giant Teva Pharmaceutical Industries (Teva) and Japan-based Takeda Pharmaceutical (Takeda) announced on 30 November 2015 that they had made a partnership to provide generics in Japan.

picture 63

Generic injectable prices stay high even after shortages resolved

Home/Pharma News | Posted 27/11/2015

Hospitals that have been struggling with shortages and subsequent high prices are now complaining that even after supply gets back to normal prices remain high. 

2014 shutterstock 233120428

Mylan will not be acquiring Perrigo

Home/Pharma News | Posted 20/11/2015

Generics company Mylan has failed in its lengthy multi-billion dollar hostile bid to acquire competing generics company Perrigo.

Pfizer cuts some biosimilars after Hospira deal

Home/Pharma News | Posted 13/11/2015

After completing its US$17 billion acquisition of Hospira, Pfizer is cutting some of its biosimilar collaborations with South Korean drugmaker Celltrion.

Shaking hands V13D29

Merck Millipore to collaborate with Turkish firm on biosimilars

Home/Pharma News | Posted 06/11/2015

The Life Science division of Merck, Merck Millipore and Turkish biosimilars start-up Turgut Ilaç are to collaborate on biosimilars.

122 MD002454

Teva acquires Mexican drugmaker Rimsa

Home/Pharma News | Posted 16/10/2015

Israeli generics giant Teva Pharmaceutical Industries (Teva) is expanding its presence in emerging markets with its acquisition of Mexico-based Representaciones e Investigaciones Medicas SA de CV (Rimsa), a specialty drugmaker with a portfolio of products and patents across Latin America.

Shaking hands V13D29

Mylan goes after Perrigo

Home/Pharma News | Posted 09/10/2015

US generics manufacturer Mylan announced on 14 September 2015 that it had officially commenced its formal offer to acquire all outstanding ordinary shares of rival Ireland-based generics maker Perrigo Company (Perrigo).

Business Aquisition V13F07

Epirus expands biosimilars pipeline with Bioceros acquisition

Home/Pharma News | Posted 02/10/2015

US-based Epirus Biopharmaceuticals (Epirus) announced on 9 September 2015 that it has acquired Netherlands-based biopharmaceutical company Bioceros Holding (Bioceros).